With real-world data to clinical evidence

With real-world data to clinical evidence

Clinical research needs real life data - SaniQ TRIAL transforms every day of study participation into valuable real world data and clinical evidence.

Arrange a demo

3 Challenges in clinical studies:

3 Challenges in clinical trials

1.

Generate real-world data

2.

Reduce the dropout rate

3.

Communicate efficiently

... und wie SaniQ TRIAL Sie dabei unterstützt:

SaniQ TRIAL turns every day of study participation into valuable real-world data that you can track in real time via the SaniQ Dashboard.

1.

Real-World-Daten
generieren

Generate real-world data

Kontinuierliche Daten

  • Telemonitoring of vital signs
  • Electronic questionnaires (PREMs & PROMs)
  • Medication planner incl. intake times
2.

Die Abbruchquote
reduzieren

Reduce the dropout rate

Bessere Compliance

  • Patient app for the active involvement of test subjects
  • Medication planner incl. reminder function in the app
  • Convenient and secure communication via televisite & chat
3.

Communicate efficiently

Communicate efficiently

Effiziente Therapiesteuerung

  • Automated monitoring alarms
  • Quick contact via chat & televisite
  • Adjustment of the dosage in the medication planner

Smart solutions for efficient clinical trials

Smart solutions for efficient clinical trials

Modules & functions
Benefits for clinics
Telemonitoring (vital signs such as blood pressure, weight, FEV1, etc.)
Continuous data collection for study endpoints, reduction of study cancellations through better compliance
Workflow Manager
Structured distribution of tasks between trial centre, CRO and investigators
Intersectoral communication
GDPR-compliant exchange between different stakeholders
Patient app
Active involvement of study participants in the course of the study and improvement of adherence
Chat & Televisite
Direct contact in the event of side effects, queries or protocol-relevant events
EDC interfaces (CDISC, CDASH, etc.):
Seamless integration into existing study management systems and electronic data capture systems
  • CE-approved Class I medical device
  • GDPR-compliant data protection and ISO 27001-certified
  • Standardised interfaces to your HIS (HL7, FHIR)
  • CE-approved
    Class I medical device
  • GDPR-compliant data protection
    and certified according to ISO 27001
  • Standardised interfaces
    to your HIS (HL7, FHIR)

Use case: Telementor COPD study

The Telementor COPD study, funded by the G-BA Innovation Fund, is using SaniQ TRIAL to investigate the benefits of telemedicine for patients with COPD. 

Period: 2022-2025

Partner: Lungenclinic Großhansdorf, Astra Zeneca, University Medical Centre Schleswig-Holstein, University Medical Centre Hamburg-Eppendorg, and many more.

Number of participants in the study: 640

Content: The Telementor COPD study is a multicentre, randomised and controlled clinical trial funded by the G-BA Innovation Fund under Consortium management of the LungenClinic Großhansdorf. The aim of the study is to prevent exacerbations in COPD patients through digital prevention and home monitoring.

Link to the study website: https://www.telementor-copd.de/

As part of the study, various vital signs of the patients are monitored using SaniQ OS and connected sensors (telespirometer, smartwatch) and analysed by the study staff:

  • Telemonitoring lung function (FEV1), heart and respiratory rate, blood-oxygen saturation and daily step count for continuous patient monitoring
  • API connection to the hospital information system for automated and bidirectional transmission of patient-related data
  • Patient app to actively involve patients in the care programme and to generate patient-reported outcomes
  • The study personnel regularly Televisits with the connected patients through

ZDF reports on COPD study with SaniQ

ZDF has reported on the Telementor COPD study, in which our SaniQ OS telemonitoring platform was used to monitor COPD patients.
to the article


Medien berichten über Studien mit SaniQ

SaniQ has already been used profitably in numerous clinical studies and research projects:

Image hover effect image

09. Juni
2026

Springer Nature

09. Juni 2026

Springer Nature

coverCHILD: Kinder mit Long COVID besser versorgen

Forschende der Philipps-Universität Marburg haben mithilfe von SaniQ untersucht, wie Telemonitoring die Versorgung von Kindern mit Post-COVID-Syndrom verbessern kann.

> zu den Studienergebnissen

Image hover effect image

05 March
2026

German Medical Journal

05 March 2026

German Medical Journal

Through the jungle of guidelines with AI

The European consortium GUIDE-AI - coordinated by Charité Berlin - is developing AI-based assistants for doctors with the help of SaniQ OS.

> to the German Medical Journal

19 Nov. 2025

ZDF media library

Image hover effect image

19 Nov.
2025

ZDF media library

ZDF report on study with SaniQ

ZDF reported on the Telementor COPD study, in which SaniQ OS was used for the medical monitoring of COPD patients.

> to the ZDF media library

What researchers say about SaniQ TRIAL

"The TIM-NIV study is investigating digital medical options for improving non-invasive home ventilation. SaniQ enables telemedical care for those affected by recording health-related data and transmitting it to the study centre in real time."
Dr Dirk Westhölter
Dr Dirk Westhölter
Clinician Scientist at the Ruhrlandklinik Essen
"Qurasoft's technical support is simply worth its weight in gold for us, because we are happy to draw on their expertise and vast experience in the areas of IT, development, regulatory affairs, etc. For us, this is the perfect complement to our clinical expertise in the field of rare diseases. "
Dr Maike Stein
Dr Maike Stein
Physician and scientist at the integrated Myasthenia Centre (iMZ) at Charité Universitätsmedizin Berlin
"We get on very well with the SaniQ telemonitoring platform. The big advantage of telemonitoring is that I can organise when I look at the platform myself - it's just important that I (or a member of staff) find the time to do it once a day - and I do!"
Ralph Rüdelstein, MD
Ralph Rüdelstein, MD
Chief Physician in the Department of Internal Medicine at St. Nikolaus Stiftshospital, Andernach
SaniQ Clinic

Request now: free live demo

In an interactive software demo, we will show you how our RPM platform SaniQ works and the benefits it offers. 

Let's talk about your project idea!

Jonas Zimmer
-Project development-

Let's talk about your project idea!

  • Personal counselling
  • Individual topic focus
  • Discover advantages

Arrange a SaniQ live demo